BACKGROUND: Household air pollution due to biomass combustion for residential heating adversely affects vulnerable populations. Randomized controlled trials to improve indoor air quality in homes of children with asthma are limited, and no such studies have been conducted in homes using wood for heating. OBJECTIVES: Our aims were to test the hypothesis that household-level interventions, specifically improved-technology wood-burning appliances or air-filtration devices, would improve health measures, in particular Pediatric Asthma Quality of Life Questionnaire (PAQLQ) scores, relative to placebo, among children living with asthma in homes with wood-burning stoves. METHODS: A three-arm placebo-controlled randomized trial was conducted in homes with wood-burning stoves among children with asthma. Multiple preintervention and postintervention data included PAQLQ (primary outcome), peak expiratory flow (PEF) monitoring, diurnal peak flow variability (dPFV, an indicator of airway hyperreactivity) and indoor particulate matter (PM) PM2:5. RESULTS: Relative to placebo, neither the air filter nor the woodstove intervention showed improvement in quality-of-life measures. Among the secondary outcomes, dPFV showed a 4.1 percentage point decrease in variability [95% confidence interval (CI) = − 7:8 to −0:4] for air-filtration use in comparison with placebo. The air-filter intervention showed a 67% (95% CI: 50% to 77%) reduction in indoor PM2:5, but no change was observed with the improved-technology woodstove intervention. CONCLUSIONS: Among children with asthma and chronic exposure to woodsmoke, an air-filter intervention that improved indoor air quality did not affect quality-of-life measures. Intent-to-treat analysis did show an improvement in the secondary measure of dPFV.
|Journal||Environmental Health Perspectives|
|State||Published - Sep 2017|
Bibliographical noteFunding Information:
The authors thank J. Balmes and K. Smith for their advice on study design. The authors also thank 3M Company for advice and materials in the design of the placebo filter. This study was funded by the National Institutes of Health/ National Institute of Environmental Health Sciences (NIH/ NIEHS) 1R01ES016336-01 and 3R01ES016336-02S1. Additional support was provided by NIGMS (1U54GM104944 and P30GM103338) and NICHD (1UG1HD090902). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
This study was funded by the National Institutes of Health/ National Institute of Environmental Health Sciences (NIH/ NIEHS) 1R01ES016336-01 and 3R01ES016336-02S1. Additional support was provided by NIGMS (1U54GM104944 and P30GM103338) and NICHD (1UG1HD090902).
© 2017, Public Health Services, US Dept of Health and Human Services. All rights reserved.
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Health, Toxicology and Mutagenesis